Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Merrimack Pharmaceuticals Inc. (MACK) just unveiled an announcement.
Merrimack Pharmaceuticals, Inc. has released its financial results for the fiscal year ended December 31, 2023, and is proposing a liquidation and dissolution plan, urging investors to read the definitive Proxy Statement before voting. The company will provide important information about the dissolution process, potential liquidating distributions, and proxy solicitation. The announcement contains forward-looking statements regarding Merrimack’s expectations and is subject to various risks and uncertainties. Investors can access more information on the SEC’s website or Merrimack’s website in the “Investors” section.
See more data about MACK stock on TipRanks’ Stock Analysis page.